XClose

UCL-TB

Home
Menu

UCL-TB open seminar: Dr Karen Jacobson on the role of substance use in TB control

19 January 2023, 2:00 pm–3:00 pm

Professor Karen Jacobson seminar

How does substance use affect transmission, treatment and control of TB?

This event is free.

Event Information

Open to

All

Availability

Yes

Cost

Free

Organiser

UCL-TB

How infectious diseases affect vulnerable populations is a major concern within UCL, and we are delighted to host an open seminar by Karen Jacobson of Boston University, who has worked in this field for many years.

Her group studies the epidemiology of infectious diseases, with a primary focus on tuberculosis. With local and international partners, they combine epidemiological approaches with bacterial and host genetic data and statistical models to explore questions about tuberculosis transmission and outcomes.

She has established a highly productive collaboration with researchers in Cape Town, South Africa. Her work has particular emphasis in understanding how substance use impacts on tuberculosis transmission and response to therapy.

She is an Associate Professor of Medicine in the Section of Infectious Diseases, Boston University School of Medicine, with a secondary appointment in the Department of Epidemiology, Boston University School of Public Health.

About the Speaker

Dr Karen Jacobson

Associate Professor of Medicine at Boston University

Dr. Karen Jacobson is an Associate Professor of Medicine in the Section of Infectious Diseases, Chobanian and Avedisian School of Medicine, with a secondary appointment in the Department of Epidemiology, Boston University School of Public Health. Dr. Jacobson’s research focuses on the epidemiology of tuberculosis, including identification of biological and social determinants of and risk factors for tuberculosis infection and disease (including drug resistant tuberculosis) and approaches for improving tuberculosis outcomes in resource-limited settings. Dr. Jacobson is the Medical Director of the Boston Medical Center Tuberculosis Clinic and has established a highly productive collaboration with researchers in Cape Town, South Africa. Her work has particular emphasis in understanding how substance use impacts on tuberculosis transmission and response to therapy.

More about Dr Karen Jacobson